Mediar Therapeutics
MA - BostonBiotechnology
Focus: Mediar Therapeutics is a Boston-based biotechnology company specializing in antibody therapies for unmet medical needs. Limited public data constrains detailed market positioning assessment.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Mediar Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Mediar Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MTX-463
HealthyClinical Trials (1)
NCT06401213A First-in-Human Safety Trial of MTX-463
Phase 1Help build intelligence for Mediar Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.